Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Brain MRI and neurological deficit measurements in focal stroke: rapid throughput validated with isradipine.

Lenhard SC, Strittmatter R, Price WJ, Chandra S, White RF, Barone FC.

Pharmacology. 2008;81(1):1-10. Epub 2007 Aug 28.

PMID:
17726342
2.

SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.

Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC.

Exp Neurol. 2008 Jul;212(1):53-62. doi: 10.1016/j.expneurol.2008.03.011. Epub 2008 Mar 25.

PMID:
18462720
3.
4.

Use of diffusion-weighted MRI and neurological deficit scores to demonstrate beneficial effects of isradipine in a rat model of focal ischemia.

Chandra S, White RF, Everding D, Feuerstein GZ, Coatney RW, Sarkar SK, Barone FC.

Pharmacology. 1999 Jun;58(6):292-9.

PMID:
10325574
5.

Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.

Campbell CA, Mackay KB, Patel S, King PD, Stretton JL, Hadingham SJ, Hamilton TC.

Exp Neurol. 1997 Nov;148(1):45-50.

PMID:
9398449
6.

Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRI.

Reese T, Pórszász R, Baumann D, Bochelen D, Boumezbeur F, McAllister KH, Sauter A, Bjelke B, Rudin M.

NMR Biomed. 2000 Oct;13(6):361-70.

PMID:
11002315
7.

[Follow-up monitoring with magnetic resonance tomography after decompressive trephining in experimental "malignant" hemispheric infarct].

Engelhorn T, Dörfler A, Egelhof T, Schwab S, Heiland S, Sartor K, Forsting M.

Zentralbl Neurochir. 1998;59(3):157-65. German.

PMID:
9816666
8.

Calcium antagonists for reduction of brain damage in stroke.

Sauter A, Rudin M.

J Cardiovasc Pharmacol. 1990;15 Suppl 1:S43-7.

PMID:
1695302
9.

Serial magnetic resonance imaging in a rat pup filament stroke model.

Ashwal S, Tone B, Tian HR, Chong S, Obenaus A.

Exp Neurol. 2006 Dec;202(2):294-301. Epub 2006 Jul 28.

PMID:
16876160
10.

Prevention of stroke and brain damage with calcium antagonists in animals.

Sauter A, Rudin M.

Am J Hypertens. 1991 Feb;4(2 Pt 2):121S-127S.

PMID:
1827001
11.

Broad-spectrum cation channel inhibition by LOE 908 MS reduces infarct volume in vivo and postmortem in focal cerebral ischemia in the rat.

Tatlisumak T, Carano RA, Takano K, Meiler MR, Li F, Sotak CH, Pschorn U, Fisher M.

Acta Neurochir Suppl. 2000;76:329-30.

PMID:
11450036
12.

Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists.

Sauter A, Rudin M, Wiederhold KH.

Neurochem Pathol. 1988 Jul-Dec;9:211-36.

PMID:
3073331
13.

Experimental studies with isradipine in stroke.

Sauter A, Rudin M.

Drugs. 1990;40 Suppl 2:44-51. Review.

PMID:
2150641
14.

DL-3-n-Butylphthalide, an anti-oxidant agent, prevents neurological deficits and cerebral injury following stroke per functional analysis, magnetic resonance imaging and histological assessment.

Zhang L, Yu WH, Wang YX, Wang C, Zhao F, Qi W, Chan WM, Huang Y, Wai MS, Dong J, Yew DT.

Curr Neurovasc Res. 2012 Aug;9(3):167-75.

PMID:
22621233
15.

Experimental intracerebral hematoma in the rat: characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy.

Belayev L, Obenaus A, Zhao W, Saul I, Busto R, Wu C, Vigdorchik A, Lin B, Ginsberg MD.

Brain Res. 2007 Jul 9;1157:146-55. Epub 2007 May 8.

PMID:
17543290
16.

Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.

Lukic-Panin V, Kamiya T, Zhang H, Hayashi T, Tsuchiya A, Sehara Y, Deguchi K, Yamashita T, Abe K.

Brain Res. 2007 Oct 24;1176:143-50. Epub 2007 Aug 2.

PMID:
17904110
17.

A temporal MRI assessment of neuropathology after transient middle cerebral artery occlusion in the rat: correlations with behavior.

Virley D, Beech JS, Smart SC, Williams SC, Hodges H, Hunter AJ.

J Cereb Blood Flow Metab. 2000 Mar;20(3):563-82.

PMID:
10724121
19.

Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender.

Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD.

Exp Neurol. 2004 May;187(1):94-104.

PMID:
15081592
20.

The dose-effectiveness of intranasal VEGF in treatment of experimental stroke.

Yang JP, Liu HJ, Wang ZL, Cheng SM, Cheng X, Xu GL, Liu XF.

Neurosci Lett. 2009 Sep 25;461(3):212-6. doi: 10.1016/j.neulet.2009.06.060. Epub 2009 Jun 24.

PMID:
19559076

Supplemental Content

Support Center